Articles

In an article for “The Marker” newspaper, Dima explains how patents can serve as a source of technological and business intelligence. He highlights how integrating patents with additional data sources can provide strategic insights and help identify opportunities.

Recognition of a Biological Substance as a “New Substance” Despite the Absence of Differences in the Primary and Secondary Structure of the Protein Compared to a Previously Registered Substance. For example, in the matter of Bayer,[8] a request for PTE was denied based on the finding that the amino acid sequence of the API in Kovaltry® […]

In a Nutshell In Unipharm v. Sanofi,[1] the Supreme Court accepted Unipharm’s claim for the restitution of profits derived by Sanofi in consequence of filing a patent application for a polymorph of an active ingredient of a drug that was protected by an earlier patent. In June 2024, the Supreme Court issued a ruling in a similar […]

A new regulatory scheme for pharmaceuticals was established in Israel. The scheme establishes a new regulatory pathway of temporary approvals for the importation and supply of pharmaceuticals during the time of the pendency of the marketing authorization applications. It also grants the HMOs the power to prioritize and affect the decision of which pharmaceuticals will […]

In December 2023, Israel’s Ministry of Health (“MoH”) published substantial revisions to the guidelines regulating policy and procedure for the registration and use of biosimilar pharmaceuticals in Israel (Procedure No. 127). The new guidelines ease requirements for registration and use of biosimilars in Israel. While the full effect of these revisions on the Israeli biopharmaceutical […]

This article was included in the AIPPI Congress News and explains the significance of the AIPPI Resolution on “Experimental Use and Bolar-type Exemptions to Patent Infringement,”, which plays an important role in pursuing global and lasting healthcare for everyone. Click here to read

Dear friends, We thank the hundreds of clients and colleagues from all over the world for their words of support and encouragement and for expressing their shock and feelings of abhorrence, pursuant to the atrocities committed by Hamas against civilians, including babies, toddlers, women, and men, young as well as elderly people, who were slaughtered […]

Ten prominent fragrance companies, including Armani, Chloe, Davidoff, Hugo Boss, Lancôme, L’Oréal, Polo, and more, recently took an Israeli ‘smell-alike’ perfume maker to court over trademark infringement. The Israeli court dismissed all claims, citing the ‘fair use’ defense, as the defendant’s use of registered trademarks was in good faith and not intended to mislead the […]

Many creators, naturally immersed in the creative process, do not always bother to regulate their copyrights as co-creators, and even if they regulate it, they seldom forget to address the question of what will happen on the day of parting – what will be the fate of the joint creation? Which of them will be […]